Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

RXST RxSight Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: RXST

Price (delayed)

$14.17

Market cap

$575.83M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.67

Enterprise value

$559.12M

Highlights
RXST's equity has surged by 70% year-on-year
RXST's gross profit has soared by 66% YoY and by 8% from the previous quarter
Sector: Healthcare
Industry: Medical Devices

Key stats

What are the main financial stats of RXST
Market
Shares outstanding
40.64M
Market cap
$575.83M
Enterprise value
$559.12M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.05
Price to sales (P/S)
3.87
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.77
Earnings
Revenue
$148.31M
Gross profit
$106.59M
Operating income
-$36.86M
Net income
-$26.55M
EBIT
-$26.46M
EBITDA
-$23.2M
Free cash flow
-$20.52M
Per share
EPS
-$0.67
EPS diluted
-$0.67
Free cash flow per share
-$0.51
Book value per share
$6.9
Revenue per share
$3.66
TBVPS
$7.73
Balance sheet
Total assets
$313.04M
Total liabilities
$33.73M
Debt
$12.04M
Equity
$279.32M
Working capital
$265.67M
Liquidity
Debt to equity
0.04
Current ratio
12.68
Quick ratio
11.48
Net debt/EBITDA
0.72
Margins
EBITDA margin
-15.6%
Gross margin
71.9%
Net margin
-17.9%
Operating margin
-24.9%
Efficiency
Return on assets
-8.5%
Return on equity
-9.5%
Return on invested capital
-9.5%
Return on capital employed
-9.1%
Return on sales
-17.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

RXST stock price

How has the RxSight stock price performed over time
Intraday
-0.7%
1 week
-5.78%
1 month
7.35%
1 year
-76.12%
YTD
-58.78%
QTD
-43.88%

Financial performance

How have RxSight's revenue and profit performed over time
Revenue
$148.31M
Gross profit
$106.59M
Operating income
-$36.86M
Net income
-$26.55M
Gross margin
71.9%
Net margin
-17.9%
RXST's gross profit has soared by 66% YoY and by 8% from the previous quarter
RxSight's net margin has soared by 59% YoY and by 9% from the previous quarter
The company's operating margin rose by 47% YoY and by 5% QoQ
RXST's revenue is up by 47% year-on-year and by 6% since the previous quarter

Price vs fundamentals

How does RXST's price correlate with its fundamentals

Growth

What is RxSight's growth rate over time

Valuation

What is RxSight stock price valuation
P/E
N/A
P/B
2.05
P/S
3.87
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.77
The EPS has grown by 46% year-on-year and by 6% since the previous quarter
RXST's equity has surged by 70% year-on-year
RXST's P/B is 65% below its last 4 quarters average of 5.9
RXST's P/S is 70% below its last 4 quarters average of 13.0
RXST's revenue is up by 47% year-on-year and by 6% since the previous quarter

Efficiency

How efficient is RxSight business performance
RXST's ROE has soared by 66% YoY and by 14% QoQ
The ROA has soared by 65% YoY and by 13% from the previous quarter
RxSight's return on invested capital has surged by 65% YoY and by 15% QoQ
The return on sales has surged by 58% year-on-year and by 9% since the previous quarter

Dividends

What is RXST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for RXST.

Financial health

How did RxSight financials performed over time
The company's total liabilities has surged by 75% YoY but it fell by 10% QoQ
The total assets has surged by 71% year-on-year
RxSight's debt is 96% less than its equity
RXST's debt to equity has surged by 100% year-on-year
RXST's equity has surged by 70% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.